- About FSPH
- Current Students
- Prospective Students
- Alumni Affairs
- Give to the School
|Departments||Type of Faculty|
Brian’s current research interests include better characterizing the clinical course and consequences of anemia and secondary hyperparathyroidism in patients with chronic kidney disease; methods for conducting post-marketing drug surveillance studies; longitudinal data analysis using large databases; and application of methods for controlling time-dependent confounding and confounding-by-indication in studies of treatment effects.
Brian D. Bradbury, MA, DSC, is currently an Adjunct Associate Professor in the Department of Epidemiology and Director in the Center for Observational Research at Amgen, Inc. leading the epidemiologic research program for medications used in the treatment of patients with kidney disease. Brian received his Doctor of Science in Epidemiology from Boston University in 2004 and a Master of Arts in Education & Psychology from Pepperdine University in 1998. Brian currently teaches the Introduction to Pharmacoepidemiology course (EPI 268). Before joining Amgen, he worked at the Boston Collaborative Drug Surveillance Program (BCDSP) conducting and publishing post-marketing drug surveillance studies. He has authored or co-authored various peer-reviewed publications in the areas of pharmacoepidemiology, cancer epidemiology and methods for controlling confounding-by-indication.
Please check with the faculty member or their office about availability to serve during current academic period.
Kilpatrick Ryan D, Gilbertson Dave, Brookhart M Alan, Polley Eric, Rothman Kenneth J, Bradbury Brian D Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions.. Pharmacoepidemiology and drug safety. 2012; 125(9): .
Brookhart M Alan, Bradbury Brian D, Avorn Jerry, Schneeweiss Sebastian, Winkelmayer Wolfgang C The effect of altitude change on anemia treatment response in hemodialysis patients.. American journal of epidemiology. 2011; 173(7): 768-77.
Ng Leslie J, Chen Fangfei, Pisoni Ronald L, Krishnan Mahesh, Mapes Donna, Keen Marcia, Bradbury Brian D Hospitalization risks related to vascular access type among incident US hemodialysis patients.. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2011; 173(7): .
Weinhandl Eric D, Peng Yi, Gilbertson David T, Bradbury Brian D, Collins Allan J Hemoglobin variability and mortality: confounding by disease severity.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2011; 57(2): 255-65.
Brookhart M Alan, Schneeweiss Sebastian, Avorn Jerry, Bradbury Brian D, Liu Jun, Winkelmayer Wolfgang C Comparative mortality risk of anemia management practices in incident hemodialysis patients.. JAMA : the journal of the American Medical Association. 2010; 303(9): 857-64.
Bradbury Brian D, Brookhart M Alan, Winkelmayer Wolfgang C, Critchlow Cathy W, Kilpatrick Ryan D, Joffe Marshall M, Feldman Harold I, Acquavella John F, Wang Ouhong, Rothman Kenneth J Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2009; 54(3): 554-60.